Followers | 13 |
Posts | 1963 |
Boards Moderated | 0 |
Alias Born | 04/16/2024 |

Friday, August 02, 2024 9:20:50 AM
I think a deal is coming on data release.... its a neglected approach. Founder is a genius and gene therapy authority, popularized AAVs. All the recent bio winners use them.
Happy trading
Recent PASG News
- Passage Bio Announces 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 07/10/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/23/2025 11:00:59 AM
- Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update • GlobeNewswire Inc. • 06/23/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2025 11:27:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 08:25:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 11:15:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 11:00:17 AM
- Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 05/13/2025 11:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/16/2025 11:02:49 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2025 11:01:31 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2025 11:00:29 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/04/2025 11:15:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 09:12:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 09:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 09:11:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/05/2025 11:09:44 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/05/2025 11:05:54 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2025 12:15:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2025 12:00:15 PM
- Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 03/04/2025 12:00:00 PM
- Passage Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/26/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2025 09:21:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 09:06:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2025 12:00:25 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM